Theravance Biopharma (TBPH) Raw Materials (2013 - 2018)

Theravance Biopharma (TBPH) has 6 years of Raw Materials data on file, last reported at $10.8 million in Q3 2018.

• On a quarterly basis, Raw Materials rose 8.41% year-over-year to $10.8 million in Q3 2018; TTM through Sep 2018 was $10.8 million, a 8.41% increase from a year earlier, with the FY2017 full-year figure at $11.7 million, up 93.32% from the prior year.
• Raw Materials for Q3 2018 stood at $10.8 million, up from $10.6 million in the prior quarter.
• Over the last five years, Raw Materials for TBPH reached as high as $11.7 million in Q4 2017 and fell as low as $4.0 million in Q1 2014.
• Historically, Raw Materials has averaged $7.6 million across 5 years, with a median of $6.9 million in 2015.
• Across the five-year window, Raw Materials fell 21.94% in 2016 and surged 93.32% in 2017, its largest moves.
• Year by year, Raw Materials stood at $6.8 million in 2014, then increased by 0.57% to $6.9 million in 2015, then slipped by 11.68% to $6.1 million in 2016, then jumped by 93.32% to $11.7 million in 2017, then retreated by 8.05% to $10.8 million in 2018.
• Per Business Quant data, the three most recent Raw Materials figures were $10.8 million in Q3 2018, $10.6 million in Q2 2018, and $10.6 million in Q1 2018.